Brown Brothers Harriman & Co’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.9K Sell
1,254
-30,584
-96% -$971K ﹤0.01% 1168
2026
Q1
$1M Sell
31,838
-31,253
-50% -$985K 0.01% 425
2025
Q4
$1.86M Hold
63,091
0.01% 293
2025
Q3
$1.59M Buy
63,091
+31,258
+98% +$762K 0.01% 278
2025
Q2
$764K Hold
31,833
﹤0.01% 374
2025
Q1
$729K Buy
+31,833
New +$768K 0.01% 339
2024
Q1
Sell
-39
Closed -$1.12K 1245
2023
Q4
$1.12K Buy
+39
New +$1.15K ﹤0.01% 1089
2023
Q3
Sell
-179
Closed -$6.98K 1297
2023
Q2
$6.98K Hold
179
﹤0.01% 1012
2023
Q1
$6.54K Hold
179
﹤0.01% 1032
2022
Q4
$5.51K Buy
+179
New +$5.56K ﹤0.01% 1091

Other funds holding RTO

Brown Brothers Harriman & Co's RTO Position: Q2 2026 in Review

Brown Brothers Harriman & Co reduced its Rentokil (RTO) stake by 96% in Q2 2026, selling an estimated $971K and leaving 1,254 shares worth $35.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1168.

Brown Brothers Harriman & Co first reported a position in RTO in Q4 2022 and has held it in 10 quarters since. The position peaked at $1.86M in Q4 2025. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Brown Brothers Harriman & Co held 1,254 shares of Rentokil worth $35.9K as of Q2 2026.
  • Brown Brothers Harriman & Co sold 30,584 Rentokil shares in Q2 2026, an estimated $971K.
  • Rentokil made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #1168 holding.
  • Brown Brothers Harriman & Co first reported a position in Rentokil in Q4 2022 and has held it in 10 quarters since.
  • Brown Brothers Harriman & Co's Rentokil position peaked at $1.86M in Q4 2025.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.